✦ LIBER ✦

High-dose cytosine arabinoside and mitoxantrone: A highly effective regimen in refractory acute myeloid leukemia

✍ Scribed by W. Hiddemann; H. Kreutzmann; K. Straif; W. D. Ludwig; R. Donhuijsen-Ant; E. Lengfelder; Th. Büchner

Book ID: 112785645
Publisher: Springer-Verlag
Year: 1986
Tongue: English
Weight: 134 KB
Volume: 111
Category: Article
ISSN: 1432-1335
DOI: 10.1007/bf02580196

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cladribine combined with high doses of a

Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group

✍ Agnieszka Wierzbowska; Tadeusz Robak; Agnieszka Pluta; Ewa Wawrzyniak; Barbara C 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB

Mitoxantrone and high-dose cytosine arab

Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia

✍ Ronald S. Walters; Hagop M. Kantarjian; Michael J. Keating; William K. Plunkett; 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

Forty-four patients with a diagnosis of refractory or relapsed acute myelogenous leukemia received salvage chemotherapy with high-dose cytosine arabinosine 3 g/m2 intravenously over 2 hours every 12 hours for six doses and mitoxantrone 5 mg/m2 intravenously daily for 5 days. Overall 16 patients (36%

Treatment of refractory acute myeloid le

Treatment of refractory acute myeloid leukemia with high-dose cytosine arabinoside and mitoxantrone in combination

✍ W. Hiddemann; H. Kreutzmann; W.D. Ludwig; H.C. Aul; R. Donhuijsen-Ant; E. Lengfe 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Mitoxantrone and high-dose cytosine arab

Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia

✍ Hagop M. Kantarjian; Ronald L. Walters; Michael J. Keating; Elihu H. Estey; SUSA 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB 👁 2 views

Twenty-five adult patients with refractory acute lymphocytic leukemia received salvage therapy with mitoxantrone 5 mg/m2 intravenously over 1 hour daily for 5 days and cytosine arabinoside 3 g/m2 intravenously over 2 hours every 12 hours for six doses. Overall, nine patients (36%) achieved complete

High dose cytosine arabinoside (HDARAC)

High dose cytosine arabinoside (HDARAC) in refractory acute leukemia

✍ Seth A. Rudnick; Edwin C. Cadman; Robert L. Capizzi; Roland T. Skeel; Joseph R. 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 2 views

Thirteen leukemic patients with disease refractory to conventional chemotherapy were treated with 1.0 to 7.5 g/m2 of Cytosine Arabinoside (Ara-C) over 29 drug cycles. Drug infusions were spaced at 12-hour intervals; a maximum of four doses was administered over 36 hours. After single dose tolerance

High-dose cytosine arabinoside and mitox

High-dose cytosine arabinoside and mitoxantrone in previously-treated acute leukemia patients

✍ C. Lejeune; N. Tubiana; J. A. Gastaut; D. Maraninchi; B. Richard; M. C. Launay; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB